Litigation Details for Par Pharmaceutical, Inc. v. Indivior Inc. (E.D. Va. 2017)
✉ Email this page to a colleague
Par Pharmaceutical, Inc. v. Indivior Inc. (E.D. Va. 2017)
| Docket | ⤷ Subscribe | Date Filed | 2017-11-13 |
| Court | District Court, E.D. Virginia | Date Terminated | 2018-05-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Claude M. Hilton |
| Jury Demand | None | Referred To | Theresa Carroll Buchanan |
| Patents | 8,475,832; 9,687,454 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Par Pharmaceutical, Inc. v. Indivior Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for Par Pharmaceutical, Inc. v. Indivior Inc. (E.D. Va. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-11-12 | 1 | that the asserted claims of U.S. Patent No. 8,475,832 (“the ’832 patent”) were invalid, and that Par did…the ’832 patent. The patent-in- suit in this case, the ’454 patent, issued from U.S. Patent Application…practice the ’454 patent, enforce the ’454 patent, and defend the validity of the ’454 patent in this judicial…that issued as the ’832 patent. The ’454 patent is related to the ’832 patent and they share a common… in asserting its invalid U.S. Patent No. 9,687,454 (“the ’454 patent”) against Par. Par and Defendants | External link to document | |
| 2017-11-12 | 3 | determination of an action regarding patent and/or trademark(s) 9,687,454. (klau, ) (Entered: 11/13/2017) … 2017 21 May 2018 1:17-cv-01280 835 Patent - Abbreviated New Drug Applications (ANDA) | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
